{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:25:24Z","timestamp":1789050324057,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.xops.2021.100086","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T19:20:38Z","timestamp":1638040838000},"page":"100086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy"],"prefix":"10.1016","volume":"2","author":[{"given":"Priyatham S.","family":"Mettu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Allingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2021.100086_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40662-016-0063-5","article-title":"Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors","volume":"3","author":"Pennington","year":"2016","journal-title":"Eye Vis (Lond)"},{"issue":"14","key":"10.1016\/j.xops.2021.100086_bib2","doi-asserted-by":"crossref","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","article-title":"The prevalence of age-related eye diseases and visual impairment in aging: current estimates","volume":"54","author":"Klein","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(97)30079-7","article-title":"Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity","volume":"104","author":"Sunness","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib4","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.ophtha.2006.12.023","article-title":"Cone- and rod-mediated dark adaptation impairment in age-related maculopathy","volume":"114","author":"Owsley","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ophtha.2008.03.009","article-title":"Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration","volume":"115","author":"Sunness","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamaophthalmol.2014.5963","article-title":"Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2021.100086_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.oret.2019.03.010","article-title":"Longitudinal study of visual function in dry age-related macular degeneration at 12 months","volume":"3","author":"Hsu","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2021.100086_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1167\/iovs.05-1222","article-title":"Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy","volume":"47","author":"Owsley","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2019.12.009","article-title":"Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective Proxima A and B clinical trials","volume":"127","author":"Holekamp","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-319-75402-4_2","article-title":"Mitochondria: potential targets for protection in age-related macular degeneration","volume":"174","author":"Brown","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xops.2021.100086_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mam.2012.04.006","article-title":"Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration","volume":"33","author":"Mettu","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.xops.2021.100086_bib13","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1523\/JNEUROSCI.0190-15.2015","article-title":"Investigating mitochondria as a target for treating age-related macular degeneration","volume":"35","author":"Terluk","year":"2015","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.xops.2021.100086_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.exer.2016.01.018","article-title":"Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration","volume":"145","author":"Ferrington","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2021.100086_bib15","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1167\/iovs.04-1224","article-title":"Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity","volume":"46","author":"Marin-Casta\u00f1o","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib16","doi-asserted-by":"crossref","first-page":"100858","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2021.100086_bib17","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1167\/iovs.10-5429","article-title":"Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration","volume":"51","author":"Karunadharma","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0161-6420(99)90356-1","article-title":"Prevalence of macular pattern dystrophy in maternally inherited diabetes and deafness","volume":"106","author":"Massin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9394(99)00057-4","article-title":"Mitochondrial maculopathy: geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation","volume":"128","author":"Latkany","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2021.100086_bib20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0161-6420(13)31404-3","article-title":"Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide\u00a03243 point mutation","volume":"100","author":"Rummelt","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4103\/jovr.jovr_182_17","article-title":"The role of mitochondria in AMD: current knowledge and future applications","volume":"12","author":"Riazi-Esfahani","year":"2017","journal-title":"J\u00a0Ophthalmic Vis Res"},{"key":"10.1016\/j.xops.2021.100086_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10741-020-10031-3","article-title":"Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide","volume":"26","author":"Sabbah","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.xops.2021.100086_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2014.03.011","article-title":"Mitochondrial reactive oxygen species production and elimination","volume":"73","author":"Nickel","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.xops.2021.100086_bib24","first-page":"1954","article-title":"Elamipretide protects RPE and improves mitochondrial function in models of AMD","volume":"58","author":"Kapphahn","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib25","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bph.12468","article-title":"Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis","volume":"171","author":"Birk","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xops.2021.100086_bib26","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xops.2021.100086_bib27","first-page":"2126","article-title":"Mitochondrial dysfunction in experimental mouse models of SubRPE\u00a0deposit formation and reversal by the mito-reparative\u00a0drug MTP-131","volume":"57","author":"Cousins","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib28","article-title":"Phase 1 clinical trial of Elamipretide in intermediate age-related macular degeneration and high-risk drusen ReCLAIM High-Risk Drusen Study","volume":"2","author":"Allingham","year":"2021","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.xops.2021.100086_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245824","article-title":"MultipleTesting.com: a tool for life science researchers for multiple hypothesis testing correction","volume":"16","author":"Menyhart","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2021.100086_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib31","first-page":"173","article-title":"The burden of age-related macular degeneration: a value-based medicine analysis","volume":"103","author":"Brown","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.xops.2021.100086_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2021.100086_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2018.02.012","article-title":"Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints","volume":"189","author":"Cocce","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2021.100086_bib34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1167\/iovs.05-0719","article-title":"Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD","volume":"47","author":"Espinosa-Heidmann","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1167\/iovs.03-0910","article-title":"Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E","volume":"45","author":"Espinosa-Heidmann","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib36","first-page":"829","article-title":"The mitochondria-targeted peptide MTP-131 prevents hydroquinone-mediated persistent injury phenotype in cultured retinal pigment epithelium cells","volume":"56","author":"Cousins","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib37","doi-asserted-by":"crossref","first-page":"E1212","DOI":"10.1212\/WNL.0000000000005255","article-title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","volume":"90","author":"Karaa","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.xops.2021.100086_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cardfail.2020.02.001","article-title":"Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: the PROGRESS-HF phase 2 trial: effects of elamipretide in heart failure","volume":"26","author":"Butler","year":"2020","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.xops.2021.100086_bib39","article-title":"Novel mitochondria-targeting peptide in heart failure treatment","volume":"10","author":"Daubert","year":"2017","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.xops.2021.100086_bib40","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1167\/iovs.13-12617","article-title":"Intrasession test-retest variability of microperimetry in age-related macular degeneration","volume":"54","author":"Wu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2021.100086_bib41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/IAE.0000000000001002","article-title":"Visual function measures in early and intermediate age-related macular degeneration","volume":"36","author":"Chandramohan","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2021.100086_bib43","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2014.02.005","article-title":"Low-luminance visual acuity and microperimetry in age-related macular degeneration","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2021.100086_bib45","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1167\/iovs.13-13199","article-title":"OCT minimum intensity as a predictor of geographic atrophy enlargement","volume":"55","author":"Stetson","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914521000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914521000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:20:08Z","timestamp":1763014808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914521000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2666914521000889"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2021.100086","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2021.100086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100086"}}